Meihua International Medical Technologies, which sells medical supplies around the world, is expected to debut this week on the Nasdaq in New York. The healthcare firm is looking to raise $57.5 million, according to data compiled for the New York Stock Exchange. While the amount is relatively small, it would mark the first listing by a Chinese company since October, when biotech firm LianBio raised $334 million on the same exchange, according to data provider Dealogic. LianBio is headquartered in both the United States and China. American investors haven’t seen an IPO from a company primarily headquartered in China since…